Yukiya Narita

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

Kei Muro, Florian Lordick, Takahiro Tsushima et al. · Annals of Oncology · 2018 · 284 citations

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS

Kei Muro, Eric Van Cutsem, Yukiya Narita et al. · Annals of Oncology · 2018 · 214 citations · Full text

Re-evaluation of HER2 status in patients with HER2-positive advanced or recurrent gastric cancer refractory to trastuzumab (KSCC1604)

Hiroshi Saeki, Eiji Oki, Tomomi Kashiwada et al. · European Journal of Cancer · 2018 · 97 citations

Her2 Status, Surgical Oncology, Oncology +6

Prospective Survey of Financial Toxicity Measured by the Comprehensive Score for Financial Toxicity in Japanese Patients With Cancer

Kazunori Honda, Bishal Gyawali, Masashi Ando et al. · Journal of Global Oncology · 2019 · 85 citations · Full text

Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison

Toshiki Masuishi, Hiroya Taniguchi, Satoshi Hamauchi et al. · Clinical Colorectal Cancer · 2016 · 74 citations

Regorafenib Versus Trifluridine/tipiracil, Surgical Oncology, Retrospective Comparison +8